Alcon Inc. (ALC)
NYSE · Healthcare · Medical Instruments & Supplies
$64.33+0.89%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $31.1B
- P/E (trailing)
- 48.7
- Forward P/E
- 16.2
- Dividend yield
- 0.6%
- 52-week range
- $61.84 – $87.64
- 52-week change
- −15.40%
- EPS (trailing)
- $1.32
- Analyst rating
- 1.6 Buy
- Next earnings
- Nov 10, 2026
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert.
Headquarters: Geneva, Switzerland · 25,000 employees · alcon.com